WTA to Require One-Time Gene Test for Women's Tennis Players

The Women's Tennis Association (WTA) has announced that all players competing in women's events will need to undergo a one-time genetic test to confirm their eligibility. The test will check for the SRY gene, a gene typically found on the Y chromosome that plays a key role in male biological development. The presence of the SRY gene indicates male sex development, while its absence is associated with female development. The WTA stated that the test is part of its commitment to ensuring fair competition in women's tennis. This decision aligns with similar policies in other sports, where governing bodies have introduced regulations to maintain fairness amidst debates over gender and eligibility. The test will be required once in a player's career, and results will be kept confidential. The move has sparked discussion among athletes and sports organizations, but the WTA emphasizes that it is a straightforward measure to uphold the integrity of women's sports. Details on implementation, including when the testing will begin and how players will be notified, are expected to be released soon.